CELLULAR BIOMEDICINE GROUP I - COM NEW (CBMG)

CUSIP: 15117P102

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class
Equity / COM NEW
Total 13F shares
694,108
Share change
+239,770
Total reported value
$12,179,089
Price per share
$17.55
Number of holders
23
Value change
+$4,271,334
Number of buys
14
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 15117P102?
CUSIP 15117P102 identifies CBMG - CELLULAR BIOMEDICINE GROUP I - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CELLULAR BIOMEDICINE GROUP I - COM NEW (CBMG) as of Q1 2018

As of 31 Mar 2018, CELLULAR BIOMEDICINE GROUP I - COM NEW (CBMG) was held by 23 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 694,108 shares. The largest 10 holders included VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, BlackRock Inc., BRIDGEWAY CAPITAL MANAGEMENT INC, GEODE CAPITAL MANAGEMENT, LLC, GOLDMAN SACHS GROUP INC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, NORTHERN TRUST CORP, Tibra Equities Europe Ltd, and CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM. This page lists 23 institutional shareholders reporting positions in this security for the Q1 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.